Biocatalysts and Biotransformation - Biocatalysts are pivotal in biotransformation processes, facilitating the conversion of substrates into desired products with high efficiency and specificity. These catalysts, typically enzymes, exhibit remarkable selectivity and activity under mild conditions, making them valuable tools in various industries including pharmaceuticals, food processing, and biofuel production. Biotransformation involves the alteration of chemical compounds through enzymatic action, often resulting in the synthesis of valuable molecules or the removal of undesirable ones. Enzymes employed as biocatalysts offer several advantages over traditional chemical catalysts, such as lower energy requirements, reduced waste generation, and compatibility with environmentally friendly processes. The specificity of biocatalysts enables precise control over reaction pathways and product stereoselectivity, contributing to the production of high-quality compounds. Furthermore, advancements in protein engineering and bioprocess optimization continue to enhance the efficiency and versatility of biocatalytic systems, driving innovation in sustainable manufacturing practices. As biocatalysis gains prominence in the synthesis of fine chemicals and pharmaceutical intermediates, ongoing research focuses on expanding the repertoire of biocatalysts and optimizing their performance for diverse applications.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Bioherbicides for eco-friendly weed management: From fields to commercialization, constraints and solutions for sustainable agriculture
K R Aneja, Kurukshetra University, India
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Utilizing complex coacervation to promote the controlled crystallization of hydrophobic drugs
Anvesha Subramanian, University of Houston, United States
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States